Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $296.4100 (-3.17%) ($295.7600 - $305.8300) on Thu. Jul. 17, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.18% (three month average) | RSI | 68 | Latest Price | $296.4100(-3.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.2% a day on average for past five trading days. | Weekly Trend | REGN advances 2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XBI(38%) XLV(38%) QQQ(31%) SPY(30%) XLK(28%) | Factors Impacting REGN price | REGN will decline at least -1.09% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.09% (StdDev 2.18%) | Hourly BBV | 0 () | Intraday Trend | -2.2% | | | |
|
Resistance Level | $299.72 | 5 Day Moving Average | $309.75(-4.31%) | 10 Day Moving Average | $310.59(-4.57%) | 20 Day Moving Average | $299.72(-1.1%) | To recent high | -6.8% | To recent low | 6.9% | Market Cap | $31.428b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |